Abstract
Marfan syndrome is one of the collagen vascular diseases that theoretically predisposes patients to excessive radiation-induced fibrosis yet there is minimal published literature regarding this clinical scenario. We present a patient with a history of Marfan syndrome requiring radiation for a diagnosis of a right brachial plexus malignant nerve sheath tumor. It has been suggested that plasma transforming growth factor beta 1 (TGF-β1) can be monitored as a predictor of subsequent fibrosis in this population of high risk patients. We therefore monitored the patient’s TGF-β1 level during and after treatment. Despite maintaining stable levels of plasma TGF-β1, our patient still developed extensive fibrosis resulting in impaired range of motion. Our case reports presents a review of the literature of patients with Marfan syndrome requiring radiation therapy and the limitations of serum markers on predicting long-term toxicity.
Author supplied keywords
Cite
CITATION STYLE
Suarez, E. M., Knackstedt, R. J., & Jenrette, J. M. (2014). Significant fibrosis after radiation therapy in a patient with Marfan syndrome. Radiation Oncology Journal, 32(3), 208–212. https://doi.org/10.3857/roj.2014.32.3.208
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.